Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104478791A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104478791A details asymmetric synthesis for Ledipasvir intermediate, ensuring high purity and cost efficiency without chiral resolution steps.